Karyopharm Therapeutics Inc. (KPTI)
MA
Total Compensation for Fiscal Year Ending in 2023: $2,626,288
| Salary | $740,000 |
|---|---|
| Bonus | $200,000 |
| Value of Stock Awards | $1,201,200 |
| Value of Option Awards | $0 |
| Non-Equity Incentive Plan Compensation | $456,950 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $28,138 |
| Total | $2,626,288 |
Karyopharm Therapeutics Inc. disclosed its CEO pay was
11
times its median employee's pay for the fiscal year ending in 2023.
How Do You Compare?
